The FDA and Juul have agreed to temporarily suspend the trial while the government conducts further review

The Food and Drug Administration and Juul on Wednesday agreed to put their legal battle on hold while the government conducts more review of the company‚Äôs electronic cigarettes. The deal comes a day after the FDA placed a team on its original order banning Juul’s products from the market and said that Juul’s application warranted “further review.”

Juul may continue to sell its e-cigarettes in the meantime, according to the federal lawsuit.

“With this administrative stay from the FDA now in place, we will continue to offer our products to adult smokers while continuing the agency’s internal audit process,” a company spokesman said in a statement.

The FDA ordered Juul to pull its products from the market on 23 June. A day later, a federal appeals court temporarily blocked the government ban at Juul’s request.

If the FDA ultimately decides to reintroduce its ban, Juul will have 30 days to seek another stay, according to the application.

To stay on the market, companies need to show that their e-cigarettes benefit public health. In practice, this means proving that adult smokers who use them are likely to quit or reduce their smoking, while teens are unlikely to get hooked on them.

FDA regulators have recently approved a handful of e-cigarettes from some of Juul’s biggest rivals, including RJ Reynolds and NJOY. But industry insiders and anti-vaping advocates had anxiously awaited an FDA decision on Juul’s products, which are the best-selling e-cigarettes in the United States.

The FDA initially said Juul’s application left regulators with significant questions, including about the chemical composition of its vaping formulations. Juul said it submitted enough information and data to resolve any issues raised.

Leave a Reply

Your email address will not be published.